Professor Mirko Trajkovski leads the Laboratory of Metabolic Diseases at the Faculty of Medicine, University of Geneva. He completed his PhD at the International Max Planck School in Dresden (2005), followed by postdoctoral research at ETH Zurich, before establishing his lab at University College London (2012) and moving to Geneva (2013). His work focuses on adipose tissue plasticity , gut microbiota , and their roles in obesity , diabetes , and insulin resistance . Swiss National Science Foundation Professor (2014) ERC Starting Grant (2014) & Consolidator Grant (2019) Dr Walter Seipp Prize & Carl Gustav Carus Prize (2005) His lab investigates fat browning mechanisms , microbiota-host communication , and multi-tissue metabolic regulation using in vivo , in vitro , and human cohort approaches. Recent publications emphasize microbiome-based therapies , temperature effects on metabolism , and gut-bone-adipose crosstalk . Current advisees include PhD student Silas Kieser, with past members like Jing Xue, Salvatore Fabbiano, and Claire Chevalier contributing to immuno-metabolism and microbial engineering projects.
Professor Athina E Markaki serves as Professor of Materials & Biomedical Engineering in the Department of Engineering at the University of Cambridge, leading research in advanced biomaterials and tissue engineering solutions for regenerative medicine with emphasis on vascularization and tubular scaffold development for human conduit replacement. Her academic credentials include a Diploma in Metallurgical Engineering (8.6/10) from the National Technical University of Athens and a PhD in Materials Science from the University of Cambridge. Markaki's research program centers on vascularisation techniques for clinically relevant tissue dimensions and tubular scaffolds to replace diseased or damaged human conduits, integrating biomaterials science with regenerative medicine principles. Key applications span liver tissue engineering, neural crest-derived stem cell differentiation, and vascular graft development, with strong translational focus on orthopaedic and cardiovascular medical devices. Analysis of her recent publications reveals dominant trends in biomimetic scaffold design, particularly collagen-based tubular structures and hydrogel systems for vascularized tissue constructs. Her work demonstrates interdisciplinary convergence of AI-driven retinal assessment, glioblastoma modeling, and self-healing cementitious materials, with consistent emphasis on clinically applicable regenerative solutions for liver, bone, and neural tissues. Her distinguished scientific contributions are recognized by major awards: Rosetrees Trust 2017 Interdisciplinary Award European Research Council (ERC) Starting Grant (2010) Advanced EPSRC Fellowship (2005) De Montfort Award at SET for Britain National Event (2004) Young Scientist Prize 2003 (5th Euromech Solid Mechanics Conference) Multiple academic excellence awards from Greek foundations Markaki directs a well-funded research program including ERC and EPSRC grants, mentoring graduate students in tissue engineering while teaching core engineering curricula covering plastic deformation, fracture mechanics, and medical materials design. Her group maintains strong industry and clinical partnerships to advance regenerative technologies. Her laboratory, accessible via http://www-memti.eng.cam.ac.uk/, specializes in vascularized tissue constructs and tubular scaffolds using laser-based manufacturing, biomimetic design, and hydrogel engineering to address critical challenges in tissue replacement and disease modeling.
Caitriona M. O'Driscoll is Professor and Chair of Pharmaceutics at University College Cork's School of Pharmacy, Ireland. With over four decades of academic experience, she previously served as Head of the School of Pharmacy at UCC from 2003-2009 and 2010-2013. Her established drug delivery research team spans from pre-formulation through to production and manufacture of prototype delivery systems suitable for clinical trial, with strong industry links underpinning many research projects. Her research interests focus on translational drug delivery with emphasis on 'problem' drugs including poorly water soluble compounds and biopharmaceuticals like peptide/protein drugs, plasma DNA and siRNA. She develops nano-sized delivery constructs that are robust enough to survive processing, stable on storage, and achieve cell/site specific delivery in vivo. Greater than 40% of new chemical entities are poorly water soluble Biopharmaceuticals now approach 50% of all new drugs in development Major barrier is design of efficient delivery systems Special focus on oral drug delivery despite challenges Analysis of her recent publications reveals a strong emphasis on targeted nanodelivery systems for cancer therapy, particularly prostate and colorectal cancer, as well as neurodegenerative diseases like Huntington's. Her work demonstrates expertise in cyclodextrin-based nanoparticles, siRNA delivery, and disease-specific formulations that account for conditions like Crohn's disease that affect drug delivery. Scientific awards include: 'Person of the Year award' by Parenteral Drug Association (Ireland Chapter) in 2013 'Award for Professional Excellence' by Helix Health in 2007/2008 'Award for Pharmacist of the Year' by Helix Health in 2007/2008 With €10.5M in career research income and 25 PhDs graduated, Professor O'Driscoll's work has attracted funding from diverse sources including Science Foundation Ireland, Enterprise Ireland, and industry partners. Her research group maintains strong links with Pharmaceutical Chemistry and Process & Chemical Engineering at UCC, creating a unique strength for drug development research from design through to clinical trial. She has served as external examiner for multiple universities and as PhD thesis examiner at institutions worldwide. Her research team operates within UCC's drug delivery group, which has established expertise spanning from pre-formulation through to production and manufacture of prototype delivery systems. The group maintains strong industry connections and offers various PhD positions, focusing particularly on translational research with product-driven applications.
Lara A. Estroff is a Full Professor and the current Chair of the Department of Materials Science and Engineering at Cornell University's College of Engineering. She has been a faculty member since 2005 and served as Director of Graduate Studies from 2015 to 2019. Her academic leadership and research excellence position her at the forefront of bio-inspired materials and biomineralization research. Her educational background includes a B.A. in Chemistry from Swarthmore College (1997) and a Ph.D. in Chemistry from Yale University (2003), followed by an NIH-funded postdoctoral fellowship at Harvard University in the lab of Prof. George M. Whitesides. Dr. Estroff's research centers on the fundamental mechanisms of crystal growth, biomineralization, and pathological mineralization. She investigates how organisms control mineral formation and applies these principles to engineer synthetic materials with complex structures and functionalities. Her work spans biomaterials, tissue engineering, and energy materials—particularly hybrid organic-inorganic perovskites for photovoltaics. She employs advanced characterization techniques and has pioneered in situ methods to monitor crystallization dynamics. Her recent publications reveal a strong trend toward interdisciplinary research, integrating materials science with cancer biology, immunology, and machine learning. The articles emphasize bio-inspired synthesis, mineral-tissue interactions, and the development of functional crystalline materials for medical and energy applications. Faculty Early CAREER Award, National Science Foundation (2009) Fiona Ip Li '78 and Donald Li '75 Excellence in Teaching Award, Cornell College of Engineering (2007) Marilyn Emmons Williams Award, Cornell Undergraduate Research Board (2009) Keynote Speaker, Gordon Research Seminar on Biomineralization (2012) Lawrence Berkeley National Lab Affiliate (2013) Dr. Estroff leads a major DOE-funded project titled “Formulation Engineering of Energy Materials via Multiscale Learning Spirals,” a $3 million, three-year initiative using machine learning to optimize perovskite synthesis for solar cells. She has advised numerous graduate students and postdoctoral researchers, and her lab is known for fostering collaborative, cross-disciplinary research. She has also contributed to educational initiatives at Cornell, particularly in undergraduate research and materials education. Her research group operates at the intersection of chemistry, engineering, and biology, focusing on high-resolution characterization of biominerals, in situ crystal growth studies, and the design of in vitro models for cell-mineral interactions. The lab actively collaborates with institutions including Lawrence Livermore National Laboratory, National Renewable Energy Laboratory, and Johns Hopkins University.
Mahmoud El-Sakka is an Associate Professor at the Department of Computer Science, University of Western Ontario since 1999. Previously, he was a faculty member at the University of Waterloo (1997–1999). He holds a B.Sc. and M.Sc. from Alexandria University (Egypt) and a Ph.D. in Systems Design Engineering from the University of Waterloo. His research focuses on medical imaging, image processing, and computer-aided diagnostics. He has served as Chair of the graduate program (2002–2007) and undergraduate program (2017–present) in Computer Science at Western Ontario. El-Sakka is a Senior Member of the IEEE and a licensed Professional Engineer in Ontario. His work spans grants from NSERC, internal university funding, and industry collaborations. Major research areas include image compression, segmentation, and medical applications like vascular analysis and echocardiography. He has led over 20 funded projects since 1999, emphasizing interdisciplinary approaches in healthcare technology. Academic contributions include advisory roles in summer programs, thesis evaluations, and conference participation. His service includes roles as Pro-Chancellor at convocations and involvement in equipment purchasing committees. Collaborations include consulting with NCR Canada and VRP Web Technology.
João F. Mano is a Full Professor at the Department of Chemistry, University of Aveiro, and Director of the Doctoral Program on Biotechnology. He leads the COMPASS Research Group and serves as Vice-Director at CICECO - Aveiro Institute of Materials. His academic appointments include Invited Professor at University of Lorraine (France), Visiting Professor at KAIST (South Korea), and Adjunct Professor at Ajou University (South Korea). Education: PhD in Chemistry (1996, Technical University of Lisbon); D.Sc. in Tissue Engineering, Regenerative Medicine and Stem Cells (2012, University of Minho) Research Interests focus on Biomaterials for Regenerative Medicine , integrating Nanotechnology , Microtechnology , and Biofabrication . His group develops Bioinspired Materials using polymer chemistry, Decellularized Extracellular Matrix , and 3D Bioprinting to engineer Cell Microenvironments for therapeutic applications. Recent Publications highlight advancements in Human-Derived Hydrogels , Photopolymerizable Scaffolds , Magneto-Responsive Biomaterials , and Programmable Bioinks . Trends show emphasis on Organ-on-a-Chip integration, Smart Living Materials , and Green Bioprinting methodologies. Scientific Awards include: European Research Council Advanced Grants (2015, 2020) Fellow at IUPAC, European Academy of Sciences, and American Institute of Medical and Biological Engineering ERC Proof of Concept Grants Doctor Honoris Causa from University of Lorraine and Utrecht UNESCO Chair on Biomaterials George Winter Award (European Society for Biomaterials) Supervisions & Collaborations encompass 74+ MSc, 26+ PhD students, and 40+ postdocs. He co-founded METATISSUE and CELLULARIS Biomodels , and serves as Editor-in-Chief of Materials Today Bio .
Benedikt Günther is a research scientist at the Technical University of Munich (TUM) working within the Chair of Biomedical Physics led by Prof. Dr. Franz Pfeiffer. His research focuses on the Munich Compact Light Source (MuCLS), a laboratory-scale inverse Compton X-ray source that provides synchrotron-like radiation for biomedical applications. Günther plays a key role in developing, optimizing, and characterizing this innovative technology, contributing to both its fundamental physics and practical medical applications. His primary research interests center around X-ray physics and imaging techniques, particularly laser enhancement cavities for inverse Compton X-ray sources, X-ray microscopy, dynamic phase-contrast imaging, and X-ray spectroscopy. Günther's work bridges fundamental physics with practical medical applications, developing instrumentation that brings synchrotron-quality imaging to conventional laboratory settings. His research has significant implications for improving medical diagnostics while making advanced imaging techniques more accessible. Analysis of Günther's publication record reveals a consistent focus on advancing compact X-ray source technology and its applications. His work demonstrates expertise in both theoretical modeling and experimental implementation, with publications spanning instrument development, imaging techniques, and specific medical applications. The research shows progression from fundamental source characterization to increasingly sophisticated biomedical applications, particularly in breast imaging, dental diagnostics, and materials science. 2019 Best Poster Award at the combined meeting of the 68th Denver X-ray Conference (DXC) & 25th International Congress on X-ray Optics and Microanalysis (ICXOM) for 'Full-Field Structured Illumination Super-Resolution X-ray Transmission Microscopy' Günther regularly presents his work at major international conferences including the International Particle Accelerator Conference, High-Brightness Sources and Light-driven Interactions Congress, and specialized X-ray imaging meetings. His research is conducted within the Munich Compact Light Source facility, a collaborative project involving physicists, engineers, and medical researchers working to develop laboratory-scale synchrotron technology for widespread biomedical use.
Hee Kwon Song, Ph.D. is an Associate Professor of Radiology at the University of Pennsylvania , affiliated with the Institute for Translational Medicine and Therapeutics and the Penn Center for Musculoskeletal Disorders . His expertise lies in MRI physics and MRI engineering , focusing on novel dynamic imaging strategies. Education: BS in Electrical Engineering, Northwestern University (1991) MS in Bioengineering, University of Pennsylvania (1994) PhD in Bioengineering, University of Pennsylvania (1999) Master of Law, University of Pennsylvania Carey Law School (2021) Dr. Song’s research specializes in dynamic contrast-enhanced MRI (DCE-MRI) using radial data acquisition and KWIC reconstruction for ultra-fast imaging. His work enables retrospective respiratory motion compensation and flexible resolution adjustments in tumor treatment monitoring ( lung, liver, breast, kidney, ovarian ). Applications extend to non-contrast MRA and tissue T1 mapping . Selected Publications demonstrate his focus on accelerated MRI , bone-selective imaging , and deep learning reconstruction , with collaborations spanning Medicine, Obstetrics and Gynecology, Neurology , and Radiation Oncology . Contact: heekwon.song@pennmedicine.upenn.edu
Amjad Javed is a Professor and Associate Dean at the University of Alabama at Birmingham , with primary appointments in the School of Dentistry - Oral & Maxillofacial Surgery and joint affiliations in Cell, Developmental and Integrative Biology , Otolaryngology , and Biomedical Engineering . His research spans bone biology, cartilage development, and myeloma bone disease. PhD in Physiology (University of the Punjab, 2003) MS in Zoology/Animal Biology (University of the Punjab, 1992) Research Interests focus on transcriptional regulation via RUNX2 and Sp7 in skeletogenesis, vascular calcification mechanisms, epigenetic control of bone formation, and tumor-bone microenvironment interactions in multiple myeloma. Key subfields include endochondral ossification, osteoclast differentiation, and nanomatrix-based tissue engineering. Scientific Contributions include discoveries about RUNX2's role in postnatal bone resorption, λ5 protein's impact on skeletal aging, and heparanase's promotion of myeloma metastasis. His work demonstrates RUNX2's dual function in chondrocyte apoptosis and cartilage degradation. Teaching & Mentorship involves graduate committee service for over 15 students and instruction in courses like Connective Tissue and Bone , Oral & Skeletal Biology , and Journal Clubs . Collaborations span Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center , Integrative Center for Aging Research , and Biomatrix Eng Regen Med Center .
Dr. Brandon K. Hadland is an Associate Professor at the University of Washington School of Medicine in Pediatrics and Fred Hutchinson Cancer Center's Translational Science and Therapeutics Division, with memberships in the Immunotherapy and Translational Data Science Integrated Research Centers. He serves as an Attending Physician at Seattle Children's Hospital for Pediatric Hematology/Oncology and Bone Marrow Transplant. Education: BS in Chemistry, Harvey Mudd College (1998) MD and PhD in Molecular Cell Biology, Washington University School of Medicine (2006) Pediatrics Residency and Internship, Seattle Children's/University of Washington (2006-2009) Pediatric Hematology/Oncology Fellowship, Seattle Children's/University of Washington/Fred Hutch (2009-2012) His research centers on embryonic hematopoietic stem cell (HSC) development, investigating Notch signaling pathways, vascular microenvironments in the AGM region and fetal liver, and engineering in vitro platforms to model blood formation. He employs single-cell functional and molecular techniques to characterize niche interactions and transcriptional programs driving HSC emergence. Recent publications demonstrate trends in applying single-cell transcriptomics to define HSC-competent hemogenic endothelium and develop stromal-free engineered niches, bridging developmental biology with therapeutic applications for blood disorders and leukemia. Dr. Hadland leads collaborative research across Fred Hutch and UW, partnering with experts in computational genomics (Dr. Cole Trapnell), stem cell engineering (Drs. Sergei Doulatov and Ying Zheng), and pediatric oncology (Drs. Soheil Meshinchi and Irv Bernstein) to advance cellular therapies and leukemia prevention strategies.
Professor Mia Woodruff is a leading academic at Queensland University of Technology (QUT), holding the position of Professor in the School of Mechanical, Medical and Process Engineering within the Faculty of Engineering. She is the Group Leader of the Biofabrication and Tissue Morphology Group and Acting Director of the Herston Biofabrication Institute. Her research focuses on biofabrication, tissue engineering, and 3D printing applications in medicine, particularly in bone regeneration, vascular surgery, and personalized prosthetics. Woodruff holds a PhD in Materials Engineering from the University of Nottingham, UK. She has led over $40 million in external grants, including ARC and Advance Queensland funding. Her work emphasizes translating biofabrication technologies into clinical practice, such as developing patient-specific implants and surgical tools. She has published over 120 peer-reviewed articles and co-founded initiatives like the Herston Biofabrication Institute to bridge clinical, research, and industry collaboration. Key research areas include composite biomaterials, 3D scanning/modelling, electrospinning, and large-animal models for bone regeneration. She has been awarded the QUT Vice Chancellor’s Research Fellowship and ARC Fellowship. Her outreach efforts include promoting STEM through media appearances and school programs, such as the 3D Printing in All High Schools initiative. Grants & Awards $40M Innovation Manufacturing CRC (Co-Investigator) $3.72M ARC Industrial Transformation Training Center (Additive Biomanufacturing) Advance Queensland Fellowships ($1.2M Cluster Grant for Biofabrication) Media & Engagement Featured in SCOPE TV, SBS The Feed , and ABC News Keynote speaker at global conferences (e.g., TERMIS, ORS) Research Infrastructure Herston Biofabrication Institute: Integrates 3D printing, clinical trials, and patient collaboration World-first Biofabrication Master’s program launched in 2014
Horst A. von Recum, PhD, is the Executive Vice Chair of the Case School of Engineering and a Professor in the Department of Biomedical Engineering at Case Western Reserve University. He is also a member of the Cancer Imaging Program at the Case Comprehensive Cancer Center. His research focuses on developing novel platforms for molecular and cellular delivery, including affinity-based systems for controlled drug release and directed stem cell differentiation. Key applications include HIV therapies, wound healing, ocular disease treatments, and tissue engineering. His work emphasizes improving drug delivery precision through molecular interactions and enhancing stem cell viability for therapeutic use. Dr. von Recum’s research interests span drug delivery systems, biomaterials science, and regenerative medicine. His lab explores cyclodextrin polymers for sustained antibiotic release, affinity-driven drug refilling mechanisms, and engineering biocompatible materials to combat implant-related infections. Recently, his team has investigated microbiome interactions with neural implants and developed polymer-based solutions for localized chemotherapy. Notable contributions include advancements in PMMA bone cement composites for drug refillable depots, cyclodextrin hydrogels for controlled release, and affinity-based systems for anti-fibrotic treatments. His work bridges materials science with clinical applications, addressing challenges in orthopedic infections, neural interfaces, and cardiovascular regeneration. Scientific achievements include over 100 peer-reviewed publications. Research funding has supported projects on antimicrobial coatings, drug delivery mechanics, and stem cell differentiation. Dr. von Recum collaborates across disciplines to translate biomaterial innovations into clinical solutions.
Dr. Neashan Mathavan is a Lecturer in the Department of Health Sciences and Technology at ETH Zürich, affiliated with the Institut für Biomechanik . His research focuses on musculoskeletal biomechanics, aging-related bone deterioration, and spatial omics approaches to study fracture healing and mechanoregulation. He has pioneered work on mouse models of premature aging (e.g., PolgA mice) to investigate sex-specific mechanisms of bone regeneration and frailty. Key areas include spatial transcriptomics, osteocyte function, and the role of mechanical loading in musculoskeletal repair. Dr. Mathavan’s research integrates advanced imaging techniques (e.g., spatial μProBe, super-resolution spatial transcriptomics) with biomechanical testing to elucidate molecular and structural changes in aging bones. His recent studies emphasize the interplay between mechanical signals and molecular pathways in bone regeneration, particularly in contexts like osteoporosis and osteoarthritis. He has also developed novel osteochondral explant models to study cartilage-bone crosstalk in osteoarthritis. His publications span 2009–2025, with a focus on translational studies linking mechanobiology to clinical outcomes. Notable contributions include investigating the efficacy of BMP-7 and zoledronate therapies in bone regeneration, as well as the role of IL-1β in osteochondral tissues. His work has implications for personalized therapies targeting musculoskeletal aging and degenerative diseases. Dr. Mathavan supervises PhD students like Riyin Tay, who explored palliative care for advanced dementia patients. He collaborates on grants involving biomechanical modeling, spatial omics, and transgenic mouse models. His laboratory at ETH Zürich’s Institut für Biomechanik is equipped for advanced imaging, mechanical testing, and molecular biology.
Andrés J. García is the Executive Director of the Parker H. Petit Institute for Bioengineering & Bioscience and a Regents’ Professor in the George Woodruff School of Mechanical Engineering at Georgia Institute of Technology. His research focuses on engineered biomaterials for regenerative medicine, including tissue repair, inflammation modulation, and cell adhesion mechanisms. He co-founded three startups (CellectCell, CorAmi Therapeutics, iTolerance) and holds multiple patents in biomaterials and drug delivery systems. Education: Ph.D., University of Pennsylvania, 1996 M.S.E., University of Pennsylvania, 1992 B.S., Cornell University, 1991 Research Interests: García’s work integrates engineering, materials science, and cell biology to develop biomaterials that direct cellular responses. Key areas include: Biomaterial platforms for bone repair and vascularization Immunomodulatory hydrogels for islet transplantation Antibacterial hydrogels for implant infection control Organoid generation using synthetic hydrogels Mechanisms of cell adhesion and mechanotransduction Publications: Over 30+ peer-reviewed articles in Nature Communications , Science Advances , Biomaterials , and others, highlighting innovations in hydrogel design, stem cell therapies, and biomaterial-driven tissue repair. Awards: Member of both the National Academy of Engineering and National Academy of Medicine (2021), Clemson Award for Basic Research (2012), and Fellowships with the American Society of Mechanical Engineers and AAAS. Labs/Teams: Leads the García Laboratory, collaborating across disciplines to translate biomaterials research into clinical applications. Active in startup partnerships and federal grants (e.g., NSF, NIH).
Bradley Nilsson is a Professor of Chemistry at the University of Rochester, Department of Chemistry. He leads the Nilsson Group, focusing on peptide self-assembly, amyloid structures, and their applications in biomedicine and materials science. His work bridges organic, biological, and materials chemistry, with notable contributions to amyloid-inspired hydrogels and HIV transmission mechanisms. He received the 2016 Goergen Award for Excellence in Teaching and the 2012 NSF CAREER Award. Education: PhD in Organic Chemistry (2003, University of Wisconsin-Madison), postdoctoral research at UC Irvine. He joined Rochester in 2006. Research interests include molecular recognition in amyloid peptides, SEVI fibrils' role in HIV transmission, and hydrogel development for tissue engineering. His lab has pioneered studies on stimulus-responsive self-assembly and co-assembly of peptides. Key achievements include the reductive trigger for peptide hydrogelation (JACS 2010), and NIH-funded work on anti-HIV microbicides. Current projects explore amyloid-β oligomer toxicity, SEVI mechanisms, and functional biomaterials from simple amino acid derivatives. Lab members include graduate students Elena Quigley, Melissa Jagrosse, Francine Yanchik, Hannah Distaffen, and Chris Jones. The lab collaborates on interdisciplinary projects funded through NIH and NSF grants.
